IV Dexketoprofen vs Placebo in Migranie Attack

• Status: Completed
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: All

Summary

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department.

H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Akdeniz University
• Treatments: Dexketoprofen trometamol

Criteria

Inclusion Criteria:

• patients presented with headache who diagnosed as migraine attack according to the international headache society

Exclusion Criteria:

• denied to give inform concent, illiterate patients, chronic renal failure, taking NSAIDs during the last six hours, pregnancy